DRUG ANALYSIS

Patient’s Medical
Name: Arnele Pilapil Age: 41 Diagnosis:

Desired
Name of Dosage, Mechanism of General General Side effects Nursing
Contraindication
Drug Route, & Action Indications and Adverse Effects Responsibilities
Frequency
Generic 40 mg/tab Inhibits HMG- To reduce risk of Contraindicated CNS: insomnia. Patient should follow a
Name: 1 tab CoA reductase, MI, stroke, in patients EENT: standard cholesterol-
Atorvastatin NGT BID an early (and angina, or hypersensitive to nasopharyngitis, lowering diet before and
Calcium rate-limiting) revascularization drug and in those pharyngolaryngeal during therapy.
step in procedures in with active liver pain. GI: abdominal
Brand cholesterol patients with disease or pain, diarrhea, Before treatment, assess
name: biosynthesis. multiple risk unexplained dyspepsia, flatulence, patient for underlying
Avamax factors for CAD persistent nausea. GU: UTI. causes for
but Is who don't elevations of Musculoskeletal: hypercholesterolemia
Therapeutic yet have the transaminase rhabdomyolysis, and obtain a baseline
class: disease. levels. arthralgia, myalgia, lipid profile.
Antilipemics extremity pain, muscle
Intensive lipid- Use cautiously in spasms, Watch for signs of
lowering after an patients with musculoskeletal pain. myositis and myopathy
ACS event hepatic Skin: rash. (unexplained muscle
regardless of impairment or pain, tenderness,
baseline LDL: heavy alcohol weakness, malaise, dark
non- use, in patients urine, fever). Drug may
cardioembolic with inadequately need to be discontinued.
stroke/TIA treated
(secondary hypothyroidism,
prevention). with other drugs
associated with
Specific Side/Adverse
myopathy, and in
Indications to Effects experienced
elderly patients.
Clients by client
Withhold or stop
drug in patients at .
risk for renal
failure caused by
rhabdomyolysis
resulting from
trauma; in
serious, acute
condition that’s
suggest
myopathy; and in
major surgery,
severe acute
infection,
hypotension,
uncontrolled
seizures, or severe
metabolic,
endocrine, or
electrolyte
disorders.
 DRUG ANALYSIS
Patient’s Medical
Name: Arnele Pilapil Age: 41 Diagnosis:

Desired
Dosage, Mechanism of General General Side effects Nursing
Name of Drug Contraindication
Route, & Action Indications and Adverse Effects Responsibilities
Frequency
Generic 300 mg, Inhibits Infections caused Contraindicated CV: thrombophlebitis. IM injection may raise
Name: NGT Q6 bacterial protein by sensitive in patients Gl: nausea, CK level in response to
Clindamycin synthesis by staphylococci, hypersensitive to pseudomembranous muscle irritation.
Hydrochloride binding 50s streptococci, drug or colitis, abdominal
subunit of the pneumococci, lincomycin. pain, diarrhea, Monitor renal, hepatic,
Brand ribosome. Bacteroides, Severe vomiting. and hematopoietic
name: Cleocin Fusobacterium, hypersensitivity Hematologic: functions during
Hydrochloride, Clostridium reactions thrombocytopenia, prolonged therapy.
Dalacin C perfringens, or requiring transient leukopenia,
other sensitive emergency eosinophilia. Hepatic: Observe patient for signs
Therapeutic aerobic and treatment have jaundice. Skin: and symptoms of
class: anaerobic been reported. maculopapular rash, superinfection.
Antibiotics organisms. Severe skin urticaria. Other:
reactions and anaphylaxis. Alert: Don't give opioid
DRESS syndrome antidiarrheals to treat
Specific Side/Adverse
have been drug-induced diarrhea;
Indications to Effects experienced
reported. they may prolong and
Clients by client
Discontinue drug worsen this condition.
if these occur.

Clindamycin use
may result in
overgrowth of
non susceptible
organisms,
particularly
yeasts. Monitor
 patient for sign of
superinfection.

Use cautiously in
neonates and
patients with
renal or hepatic
disease, asthma,
history of GI
disease, or
significant
allergies.

Severe or fatal
reactions such as
toxic epidermal
necrolysis have
been reported.
Discontinue drug
if severe skin
reaction occurs.

DRUG ANALYSIS
Patient’s Medical
Name: Arnele Pilapil Age: 41 Diagnosis:

Desired
Name of Dosage, Mechanism of General General Side effects
Contraindication Nursing Responsibilities
Drug Route, & Action Indications and Adverse Effects
Frequency
Generic 0.25 mg/ IV Inhibits sodium- HF, rapid Contraindicated CNS: agitation, Drug-induced
Name: now potassium- digitalization in patients fatigue, generalized arrhythmias may
Digoxin activated hypersensitive muscle weakness, increase the severity of
adenosine Hf, gradual to drug and in hallucinations, HF and hypotension.
Brand triphosphate, digitalization those with dizziness, headache,
name: promoting digitalis-induced malaise, paresthesia, Patients with
Lanoxin movement of Atrial fibrillation toxicity, stupor, vertigo. CV: hypothyroidism are
calcium from (chronic) arrhythmias, heart extremely sensitive to
ventricular
Therapeutic extracellular to block. EENT: blurred cardiac glycosides and
fibrillation, or
class: intracellular vision, diplopia, light may need lower doses.
Inotropes cytoplasm and ventricular flashes, photophobia,
strengthening tachycardia yellow-green halos Monitor patient for
myocardial unless caused by around visual images. toxicity. Toxic effects on
contraction. HF. Gl: anorexia, nausea, the heart may be life-
Also acts on diarrhea, vomiting. threatening and require
CNS to enhance Don't use in immediate attention.
Specific Side/Adverse
vagal tone, patients with Signs and symptoms of
Indications to Effects experienced
slowing Wolff-Parkinson- toxicity include anorexia,
Clients by client
conduction White syndrome nausea, vomiting, visual
through the SV unless the con- changes, and cardiac
and AV nodes. duction accessory arrhythmias. Patients
pathway has with low body weight,
been advanced age, renal
pharmacologically impairment, and
electrolyte disturbances
or surgically
are at increased risk.
disabled.
Alert: Excessively slow
Use with extreme pulse rate
caution in elderly (60 beats/minute [bpm]
patients and in or less) may be a sign of
those with acute digitalis toxicity.
MI, incomplete Withhold drug and notify
AV block, sinus prescriber.
bradycardia,
PVCs, chronic Monitor potassium level
 constrictive carefully. Take
pericarditis, corrective action before
hyper- hypokalemia occurs.
trophic Hyperkalemia may result
cardiomyopathy, from digoxin toxicity.
renal
insufficiency,
severe pulmonary
disease, or
hypothyroidism.

DRUG ANALYSIS
Patient’s Medical
Name: Arnele Pilapil Age: 41 Diagnosis:

Desired
Name of Dosage, Mechanism of General General Side effects Nursing
Contraindication
Drug Route, & Action Indications and Adverse Effects Responsibilities
Frequency
Generic 40 mg, IV Inhibits proton Maintenance of Contraindicated CNS: anxiety, Symptomatic response to
Name: Q12 pump activity healing of erosive asthenia, dizziness, therapy doesn't preclude
Pantoprazole by binding to esophagitis. in patients headache, insomnia, the presence of gastric
Sodium hydrogen- hypersensitive to migraine, pain, malignancy.
potassium Short-term depression, vertigo.
Brand adenosine treatment of any component of CV: chest pain, edema, Alert: Prolonged use of
name: triphosphatase, erosive the formulation. thrombophlebitis. PPIs may cause to low
Pantoloc, located at esophagitis EENT: blurred vision, magnesium levels.
Protonix, secretory associated with pharyngitis, rhinitis, Monitor magnesium
Protonix IV surface of GERD. sinusitis. GI: levels before start of
gastric parietal PPI therapy may abdominal pain, treatment and
Therapeutic cells, to Long-term be associated with constipation, diarrhea, periodically thereafter.
class: suppress gastric maintenance of dyspepsia, eructation,
Antiulcer secretion. healing erosive an increased risk flatulence, Alert: Monitor patient
drugs esophagitis and of osteoporosis- gastroenteritis, GI for signs and symptoms
reduction in disorder, nausea, rectal of low magnesium level,
related fractures.
relapse rates of disorder, vomiting. such as abnormal HR or
daytime and Patients should GU: urinary rhythm, palpitations,
nighttime use lowest dose frequency, UTI. muscle spasms, tremor,
heartburn Hematologic: or seizures. Magnesium
symptoms in and shortest leukopenia, supplementation or drug
patients with duration of thrombocytopenia. discontinuation may be
GERD. Hepatic: of elevated required.
therapy
liver enzyme levels.
Treatment of appropriate to Metabolic:
pathologic condition being hyperglycemia,
hypersecretion hyperlipidemia.
caused by treated. Musculoskeletal:
Zollinger-Ellison arthralgia, back pain,
syndrome. hypertonia, neck pain.
Respiratory:
Dyspepsia. bronchitis, a dyspnea,
increased cough, URI.
Skin: rash, pruritus,
urticaria. Other: flulike
syndrome, infection,
injection-site reaction,
photosensitivity
reactions.
Specific Side/Adverse
Indications to Effects experienced
Clients by client
.